Thomas R Staab II insider trades: Tenax Therapeutics (TENX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
38 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | TENX | ↑ Buy | 5,675 | $1.94 | $11K | Direct | Sep 15, 2026 (4d) |
| Dec 7, 2022 | LNSR | ↑ Buy | 2,752 | $3.16 | $9K | Direct | Dec 7, 2022 (0d) |
| May 17, 2019 | BCRX | ↓ Sell | 9,750 | $7.65 | $75K | Direct | May 20, 2019 (3d) |
| May 15, 2019 | BCRX | ↓ Sell | 11,750 | $7.81 | $92K | Direct | May 16, 2019 (1d) |
| May 13, 2019 | BCRX | ↓ Sell | 19,500 | $7.70 | $150K | Direct | May 13, 2019 (0d) |
| May 6, 2019 | BCRX | ↓ Sell | 16,750 | $7.54 | $126K | Direct | May 6, 2019 (0d) |
| Apr 4, 2019 | BCRX | ↓ Sell | 7,500 | $8.81 | $66K | Direct | Apr 8, 2019 (4d) |
| Jan 28, 2019 | BCRX | ↓ Sell | 5,000 | $9.85 | $49K | Direct | Jan 30, 2019 (2d) |
| Dec 4, 2018 | BCRX | ↓ Sell | 3,922 | $9.45 | $37K | Direct | Dec 6, 2018 (2d) |
| Nov 23, 2018 | BCRX | ↓ Sell | 15,500 | $9.32 | $144K | Direct | Nov 26, 2018 (3d) |
| Nov 20, 2018 | BCRX | ↓ Sell | 11,198 | $8.67 | $97K | Direct | Nov 21, 2018 (1d) |
| Nov 8, 2018 | BCRX | ↓ Sell | 14,087 | $8.12 | $114K | Direct | Nov 9, 2018 (1d) |
| Nov 5, 2018 | BCRX | ↓ Sell | 215 | $8.00 | $2K | Direct | Nov 7, 2018 (2d) |
| Nov 2, 2018 | BCRX | ↓ Sell | 10,856 | $7.84 | $85K | Direct | Nov 6, 2018 (4d) |
| Oct 19, 2018 | BCRX | ↓ Sell | 3,150 | $7.45 | $23K | Direct | Oct 23, 2018 (4d) |
| Oct 3, 2018 | BCRX | ↓ Sell | 9,850 | $7.24 | $71K | Direct | Oct 4, 2018 (1d) |
| Mar 20, 2017 | BCRX | ↓ Sell | 3,250 | $9.20 | $30K | Direct | Mar 22, 2017 (2d) |
| Mar 10, 2017 | BCRX | ↓ Sell | 3,250 | $9.06 | $29K | Direct | Mar 14, 2017 (4d) |
| Mar 8, 2017 | BCRX | ↓ Sell | 6,500 | $8.43 | $55K | Direct | Mar 10, 2017 (2d) |
| Mar 6, 2017 | BCRX | ↓ Sell | 3,250 | $7.90 | $26K | Direct | Mar 8, 2017 (2d) |
| Dec 19, 2016 | BCRX | ↓ Sell | 3,250 | $7.45 | $24K | Direct | Dec 21, 2016 (2d) |
| Aug 12, 2016 | BCRX | ↓ Sell | 5,864 | $5.18 | $30K | Direct | Aug 15, 2016 (3d) |
| Aug 9, 2016 | BCRX | ↓ Sell | 14,577 | $4.43 | $65K | Direct | Aug 11, 2016 (2d) |
| Dec 21, 2015 | BCRX | ↓ Sell | 3,052 | $10.86 | $33K | Direct | Dec 22, 2015 (1d) |
| Dec 17, 2015 | BCRX | ↓ Sell | 3,000 | $10.49 | $31K | Direct | Dec 18, 2015 (1d) |
| Jul 20, 2015 | BCRX | ↓ Sell | 3,500 | $16.50 | $58K | Direct | Jul 22, 2015 (2d) |
| Jun 22, 2015 | BCRX | ↓ Sell | 3,750 | $16.00 | $60K | Direct | Jun 24, 2015 (2d) |
| Jun 19, 2015 | BCRX | ↓ Sell | 16,375 | $14.36 | $235K | Direct | Jun 22, 2015 (3d) |
| Jun 5, 2015 | BCRX | ↓ Sell | 6,000 | $12.75 | $77K | Direct | Jun 9, 2015 (4d) |
| Jun 1, 2015 | BCRX | ↓ Sell | 3,000 | $12.00 | $36K | Direct | Jun 2, 2015 (1d) |
| May 18, 2015 | BCRX | ↓ Sell | 3,000 | $11.00 | $33K | Direct | May 19, 2015 (1d) |
| Dec 29, 2014 | BCRX | ↓ Sell | 9,500 | $12.56 | $119K | Direct | Dec 31, 2014 (2d) |
| Aug 27, 2014 | BCRX | ↓ Sell | 10,000 | $13.58 | $136K | Direct | Aug 29, 2014 (2d) |
| Jul 1, 2014 | BCRX | ↓ Sell | 3,125 | $13.00 | $41K | Direct | Jul 2, 2014 (1d) |
| Jun 23, 2014 | BCRX | ↓ Sell | 3,125 | $12.49 | $39K | Direct | Jun 24, 2014 (1d) |
| Jun 17, 2014 | BCRX | ↓ Sell | 3,125 | $12.00 | $38K | Direct | Jun 19, 2014 (2d) |
| Mar 14, 2014 | BCRX | ↓ Sell | 3,125 | $11.24 | $35K | Direct | Mar 17, 2014 (3d) |
| Mar 4, 2014 | BCRX | ↓ Sell | 3,000 | $12.69 | $38K | Direct | Mar 7, 2014 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TENX insiders
Open-market trades in the last 12 months
About Thomas R Staab II's insider trades
Thomas R Staab II is Chief Financial Officer at Tenax Therapeutics (TENX). Since Mar 4, 2014, Thomas has reported 2 open-market purchases worth $20K and 36 sales worth $2.4M on SEC Form 4. In the last 12 months: 1 buy ($11K).
Their filings also include grants and awards (47 filings), option exercises (36 filings), shares withheld for taxes (25 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TENX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.